• Profile
Close

Prenatal treatment and outcomes of women with opioid use disorder

Obstetrics and Gynecology Sep 28, 2018

Brogly SB, et al. - In pregnant women with opioid use disorder, this prospective cohort study was undertaken to characterize the traits, treatment, and outcomes. Data suggest these pregnant women represent a clinically complex population with prevalent polysubstance use, economic instability, legal problems, trauma histories, and comorbidities.

Methods

  • Researchers enrolled women attending an obstetric and addiction recovery clinic in Boston from 2015 to 2016 in a prospective cohort study and followed them through delivery (N=113).
  • Clinically, buprenorphine or methadone was administered to the women.
  • They administered the Addiction Severity Index at enrollment.
  • Medical charts were used to abstract prenatal and delivery data systematically.

Results

  • The cohort was comprised of non-Hispanic white (80.5%) women mostly; mean age was 28 years and only 8.9% of the women were married.
  • In this cohort, more than half had been incarcerated, 29.2% had current legal involvement, and 15.0% generally had unstable housing.
  • Hepatitis C infection (70.8%) and histories of sexual (56.6%) and physical (65.5%) abuse were prevalent in majority of these women.
  • Heroin (92.0%), injection heroin (83.2%), other opioids (69.0%), marijuana (73.5%), alcohol (56.6%), and cocaine (62.8%) were used by this cohort.
  • Initially, treatment with prenatal buprenorphine was provided to 59 women (52.2%) and with methadone to 54 women (47.8%); 49.6% were also receiving concomitant psychotropic medications.
  • Choice of treatment did not impact opioid use relapse (44.7% overall).
  • Positive opioid screens mainly accounted for transition to methadone among 13 (22.5%) of 59 women treated with buprenorphine.
  • Clinical care was discontinued in, overall, 23.0% (n=26) of the cohort.
  • They noted a small number of pregnancy losses (three therapeutic abortions, four miscarriages, one stillbirth), with an overall live birth rate of 90.8% (95% CI 82.7–95.9).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay